Nurse Practitioner, Acute Care · Little Rock, AR
NPI
1518923903
Since 2006
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
800 Fair Park Blvd
Little Rock, AR, 72204
Phone (501) 404-8007
Groups this clinician bills Medicare through
Medicare paid, 2024
$810K
70,682 services
Medicare patients, 2024
458
Average age 71
Drug cost, 2024
$1.6M
6,003 prescriptions
Company payments, 2025
$1,070
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Debra G Brent was code J3262 (injection, tocilizumab, 1 mg), 18,167 times for 11 patients. In total Debra G Brent billed 70,682 services in 85 codes, and Medicare paid $810K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 18,167 | 11 | $4.70 | $85K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 9,684 | 55 | $0.10 | $980 |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 8,190 | 11 | $8.65 | $71K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 7,900 | 19 | $8.51 | $67K |
| J0897 Injection, denosumab, 1 mg | Office | 3,300 | 44 | $20.56 | $68K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2,072 | 21 | $22.25 | $46K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,789 | 14 | $24.41 | $44K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,456 | 24 | $0.23 | $330 |
| 99214 Office E&M - Established | Office | 671 | 316 | $70.72 | $47K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 300 | 54 | $5.43 | $1,629 |
| 99213 Office E&M - Established | Office | 274 | 194 | $45.21 | $12K |
| 73620 X-ray - Lower Extremity | Office | 195 | 99 | $16.35 | $3,189 |
| 96415 Chemotherapy Administration | Office | 168 | 49 | $15.45 | $2,595 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 144 | 15 | $0.49 | $71.18 |
| 73120 X-ray - Upper Extremity | Office | 143 | 73 | $18.25 | $2,610 |
By year: 2022 $1.2M for 73,368 services; 2023 $1.2M for 94,098 services; 2024 $810K for 70,682 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 84 | 12 | $15.10 | $1,268 |
| 82306 Clinical Chemistry | 36 | 36 | $27.65 | $995 |
| 86225 Immunoassay | 12 | 12 | $11.57 | $139 |
| 86226 Immunoassay | 12 | 12 | $10.20 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug Debra G Brent prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,083 prescriptions and refills. In total Debra G Brent wrote 6,003 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,083 | 2,267 | 394 | $48K |
| Methotrexate Methotrexate Sodium | 438 | 817 | 150 | $8,960 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 382 | 382 | 104 | $8,259 |
| Gabapentin Generic | 376 | 853 | 152 | $6,812 |
| Prednisone Generic | 368 | 688 | 145 | $3,513 |
| Tramadol Hcl Generic | 362 | 370 | 88 | $1,962 |
| Diclofenac Sodium Generic | 335 | 589 | 109 | $6,129 |
| Leflunomide Generic | 247 | 475 | 84 | $15K |
| Sulfasalazine Generic | 225 | 474 | 93 | $4,611 |
| Colchicine Generic | 217 | 425 | 83 | $22K |
| Duloxetine Hcl Generic | 181 | 418 | 74 | $3,785 |
| Pregabalin Generic | 139 | 229 | 51 | $6,828 |
| Folic Acid Generic | 130 | 305 | 43 | $847 |
| Pilocarpine Hcl Generic | 118 | 183 | 36 | $5,702 |
| Meloxicam Generic | 112 | 267 | 50 | $482 |
Brand drugs: 534 claims; generic drugs: 5,469 claims; opioid claims: 813.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Debra G Brent $1,070 ($1,070 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $474.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 32 | $474 |
| Amgen Inc. AMGN | 25 | $235 |
| UCB, Inc. UCB.BR | 7 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61.77 |
| GlaxoSmithKline, LLC. GSK | 3 | $48.54 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $24.32 |
| United Therapeutics Corporation UTHR | 1 | $24.32 |
| Pfizer Inc. PFE | 1 | $17.6 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.71 |
| Kedrion Biopharma, Inc. | 1 | $14.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.